Revocations, savings and transitional provisionsE+W

5.—(1) The instruments specified in column 1 of the table in Schedule 3 are revoked to the extent specified in column 3 of that table, subject to paragraph (2).

(2) The instruments specified in column 1 of the table in Schedule 3 continue to have effect (so far as otherwise revoked to the extent specified in column 3 of that table)—

(a)until 21 February 2021 in respect of infant formula and follow-on formula manufactured from protein hydrolysates;

(b)for the purposes of paragraph (3)(b).

(3) Infant formula and follow-on formula which does not comply with a specified EU law requirement may continue to be marketed until stocks of such food are exhausted, provided that—

(a)it was placed on the market or labelled—

(i)before 22 February 2020; or

(ii)before 22 February 2021 in the case of infant formula and follow-on formula manufactured from protein hydrolysates; and

(b)the conditions specified in the following provision of the Infant Formula and Follow-on Formula (Wales) Regulations 2007 M1 are met—

(i)regulation 3(1) (prohibition on the marketing of infant formula unless certain conditions are met) in the case of infant formula;

(ii)regulation 3(2) (prohibition on the marketing of follow-on formula unless certain conditions are met) in the case of follow-on formula.

[F1(4) Regulations 2 to 4 do not apply in respect of infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.

(5) Schedule 4 makes provision in relation to infant formula and follow-on formula manufactured from protein hydrolysates until 22 February 2022.]